Turnstone Biologics Corp. Announces Delisting from Nasdaq Following Merger Completion
Reuters
Aug 11, 2025
<a href="https://laohu8.com/S/TSBX">Turnstone Biologics Corp.</a> Announces Delisting from Nasdaq Following Merger Completion
Turnstone Biologics Corp. has announced a regulatory action related to its merger with XOMA Royalty Corporation. Following the completion of the merger, Turnstone has notified the Nasdaq Capital Market LLC of the merger's consummation and requested the suspension of trading of its shares, effective before the opening of trading on August 11, 2025. Additionally, Turnstone has filed a Notification of Removal from Listing and/or Registration on Form 25 with the SEC to effect the delisting of all its shares from Nasdaq. The company also plans to file a Certification and Notice of Termination of Registration on Form 15 to terminate the registration of its shares under Section 12(g) of the Securities Exchange Act of 1934 and suspend reporting obligations under Sections 13 and 15(d) of the Exchange Act.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Turnstone Biologics Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-177597), on August 11, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.